Since there are strong associations between human autoimmune diseases and certain HLA class II types, and CD4+ T-cells play a central role in the initiation, progression and maintenance of most, if not all autoimmune diseases, we reasoned that these pMHCII-based compounds would have superior translational significance than their pMHCI-based counterparts. This evidence concerns the gene CD4 and autoimmune disease.